Aromatase inhibitors safe and effective for treating male infertility, says study
China: Aromatase inhibitors (AIs) may be effective for the treatment of male infertility, according to a recent study in the journal Andrology. AIs discontinuation for 2-7 days before sperm retrieval may increase the success rate of fertilization for infertile male patients planning assisted reproduction.
For decades, aromatase inhibitors has been utilized for treating male fertility. Still, the safety and efficacy of AIs in the treatment of male infertility remain controversial due to the lack of large-scale randomized controlled studies and basic research. Therefore, there is a need to conduct an evidence-based preliminary evaluation of the existing clinical trials of AIs in the treatment of male infertility.
Considering the above, Jian-guo Liu, Department of Andrology, Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, China, and colleagues conducted a systematic review with a meta-analysis of all available studies reporting sperm conventional parameters, gonadotropin and testosterone levels, and/or the pregnancy rate. They performed a comprehensive literature search in the PubMed, Embase, Cochrane, CNKI, VIP, CBM, and Wanfang databases through August 2021 for all studies. A total of 10 studies involving 666 patients were included.
Based on the study, the researchers reported the following findings:
- Letrozole (LE) or anastrozole (AZ) administration significantly increased sperm concentration, total sperm count, serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone (T) levels, and the testosterone-to-estradiol ratio (T/E2), but E2 levels were significantly reduced compared with baseline values.
- Compared with the control group, which included selective estrogen receptor modulators (SEMRs) or human chorionic gonadotropin (HCG), LE, or AZ did not have any significant effect on sperm concentration, motility, and morphology, except that AIs had less effect on sperm motility than the control group (weighted mean difference [WMD]: −2.55).
To conclude, "AIs may be an effective treatment for male fertility. For infertile male patients planning assisted reproduction, discontinuation of AIs for 2–7 days prior to sperm retrieval may increase the success rate of fertilization."
"Further studies with larger sample sizes are needed to validate these findings," the researchers wrote.
Reference:
Guo B, Li JJ, Ma YL, Zhao YT, Liu JG. Efficacy and safety of letrozole or anastrozole in the treatment of male infertility with low testosterone-estradiol ratio: A meta-analysis and systematic review. Andrology. 2022 Apr 19. doi: 10.1111/andr.13185. Epub ahead of print. PMID: 35438843.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.